CD8A and glioma: Mice bearing GL-26 gliomas in the right corpus striatum when treated with direct intratumoral administration of replication-deficient adenoviral AdmIL-12 vector, it significantly prolonged the survival of glioma bearing animals with robust infiltration of CD4+ and CD8+ T-cells (Liu et al., 2002).